Econographics

There is no alternative to US Treasuries

By Josh Lipsky

In the wake of a US default, investors searching for safe assets may have no viable alternative to US Treasuries.

Can FedNow bring the US closer to real-time payments?

By Piret Loone

This year, the US will launch its FedNow instant payment network. But even after FedNow launches, the US will still have a ways to go before consumers can access instantaneous digital payments.

The US debt ceiling stalemate threatens money market funds—and financial stability

By Hung Tran

Money markets would be the first to react to a debt ceiling breach, heightening market turmoil at the wrong time and helping to raise the odds of a severe recession.

What is the G7 still exporting to Russia? 

By Niels Graham

One year into the Russia’s invasion G7 nations continue to export nearly $5B a month to Moscow. A new proposal by the US at the G7 could greatly reduce this.

Japan’s monetary trilemma is a warning to the world

By Mark Siegel

High inflation, high levels of debt, and uncertain financial stability – Washington, London, Brussels, Frankfurt and beyond have much to learn from Tokyo’s experience.

Russia Sanctions Database: May 2023

Explore featured insight part of the May 2023 edition of Atlantic Council’s Russia Sanctions Database.

The root causes of geopolitical fragmentation

By Hung Tran

Geoeconomic fragmentation is on the rise. Policymakers need to address the root causes: inequality left in the wake of globalization, and the crisis of trust between major countries.

Why emerging markets are stocking up on gold

By Phillip Meng

Financial stability concerns, sanctions, and inflation contributed to the largest net purchases of gold in over seventy years last year—raising questions about its potential role in de-dollarization.

Practice makes perfect: What China wants from its digital currency in 2023

By Ananya Kumar

The e-CNY network has expanded over the last year, and China’s goals have only become clearer. Domestically, the People’s Bank of China is still in test-and-learn mode, globally, China is more focused on setting defining international standards.

The US is relying more on China for pharmaceuticals—and vice versa 

By Niels Graham

US China trade of pharmaceutical and active pharmaceutical ingredient (API) is rapidly increasing. Supply chain mapping will be key to risk management